CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative adjustment upon adoption of ASC 326 (Note 1)	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative adjustment upon adoption of ASC 326 (Note 1)
Beginning balance (in shares) at Jan. 31, 2019			126,246
Beginning balance at Jan. 31, 2019	$ 307,478		$ 12	$ 653,738	$ (3,036)	$ (343,236)
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Stock-based compensation	$ 82,355			82,355
Repayment of promissory notes, net of early exercises	11,813			11,813
Exercise of stock options, net of repurchases and early exercises (in shares)			4,619
Exercise of stock options, net of repurchases and early exercises	21,977		$ 1	21,976
Vesting of restricted stock units (in shares)			3,454
Issuance of common stock under employee stock purchase plan (in shares)			1,176
Issuance of common stock under employee stock purchase plan	18,565			18,565
Net loss	(149,217)					(149,217)
Foreign currency translation adjustments	(1,290)				(1,290)
Ending balance (in shares) at Jan. 31, 2020			135,495
Ending balance at Jan. 31, 2020	291,681	$ (558)	$ 13	788,447	(4,326)	(492,453)	$ (558)
Stock-based compensation	107,501			107,501
Exercise of stock options, net of repurchases and early exercises (in shares)			2,916
Exercise of stock options, net of repurchases and early exercises	18,855		$ 1	18,854
Vesting of restricted stock units (in shares)			4,666
Issuance of common stock under employee stock purchase plan (in shares)			425
Issuance of common stock under employee stock purchase plan	17,678			17,678
Net loss	(153,967)					(153,967)
Foreign currency translation adjustments	(3,202)				(3,202)
Other	25			25
Ending balance (in shares) at Jan. 31, 2021			143,502
Ending balance at Jan. 31, 2021	278,013		$ 14	932,505	(7,528)	(646,978)
Stock-based compensation	155,337			155,337
Exercise of stock options, net of repurchases and early exercises (in shares)			1,377
Exercise of stock options, net of repurchases and early exercises	13,440		$ 1	13,439
Vesting of restricted stock units (in shares)			3,733
Issuance of common stock under employee stock purchase plan (in shares)			477
Issuance of common stock under employee stock purchase plan	19,678			19,678
Net loss	(203,599)					(203,599)
Foreign currency translation adjustments	(168)				(168)
Ending balance (in shares) at Jan. 31, 2022			149,089
Ending balance at Jan. 31, 2022	$ 262,701		$ 15	$ 1,120,959	$ (7,696)	$ (850,577)

Anaplan, Inc. 10-K